Identification of MAPK10 as a novel epigenetic marker for chromophobe kidney cancer

Pathology International

Volumn 61, Issue 1, 2011, Pages 52-54

  Yoo, Koo Han ^a   Park, Yong Koo ^a   Kim, Hyun Sook ^b   Jung, Woon Won ^b   Chang, Sung Goo ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MITOGEN ACTIVATED PROTEIN KINASE 10;

ADULT; AGED; CANCER GENETICS; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC MARKER; HEREDITY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LETTER; MALE; PRIORITY JOURNAL;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 10;

EID: 78650231180     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2010.02605.x     Document Type: Letter

References (10)

1. Nagashima Y. Chromophobe renal cell carcinoma: Clinical, pathological and molecular biological aspects. Pathol Int 2000; 50: 872-8.
2. Thoenes W, Storkel S, Rumpelt HJ, Moll R, Baum HP, Werner S. Chromophobe cell renal carcinoma and its variants - a report on 32 cases. J Pathol 1988; 155: 277-87.
3. Bugert P, Gaul C, Weber K et al. Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Lab Invest 1997; 76: 203-8.
4. Contractor H, Zariwala M, Bugert P, Zeisler J, Kovacs G. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour. J Pathol 1997; 181: 136-9.
5. Petit A, Castillo M, Santos M, Mellado B, Alcover JB, Mallofre C. KIT expression in chromophobe renal cell carcinoma: Comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms. Am J Surg Pathol 2004; 28: 676-8.
6. Pavlovich CP, Walther MM, Eyler RA et al. Renal tumors in the Birt-Hogg-Dube syndrome. Am J Surg Pathol 2002; 26: 1542-52.
7. Bibikova M, Lin Z, Zhou L et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res 2006; 16: 383-93.
8. Yoo KH, Park YK, Kim HS, Jung WW, Chang SG. Epigenetic inactivation of HOXA5 and MSH2 gene in clear cell renal cell carcinoma. Pathol Int 2010.
9. Tournier C, Hess P, Yang DD et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 2000; 288: 870-4.
10. Ying J, Li H, Cui Y, Wong AH, Langford C, Tao Q. Epigenetic disruption of two proapoptotic genes MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas through hypermethylation of a common bidirectional promoter. Leukemia 2006; 20: 1173-5.